J&J buys medical robotics company for $3.4 bn

Johnson & Johnson announced a $3.4 billion acquisition of robotics company Auris Health.
Johnson & Johnson announced a $3.4 billion acquisition of robotics company Auris Health.

US healthcare and consumer products giant Johnson & Johnson announced Wednesday it will acquire medical robotics company Auris Health for $3.4 billion, arguing the technology will become more central to surgery.

Privately-held Auris has the opportunity to earn up to $2.35 billion in additional payments if it meets "predetermined milestones," J&J said in a press release.

"In this new era of health care, we're aiming to simplify surgery, drive efficiency, reduce complications and improve outcomes for patients, ultimately making surgery safer," said J&J Executive Vice President Ashley McEvoy said in a statement.

Combining robotics into healthcare "will make a meaningful difference in patient outcomes."

Auris' founder, Frederic Moll, has been known as a long-time leader in , which is seen as offering potential to improve because of the ability to execute tremor-free movements and handle small tools.

Auris initially was focused on lung cancer. J&J said the company's machinery would be integrated with its other digital assets to improve patient treatment for the from detection through intervention.

Shares of J&J rose 0.5 percent to $134.78 in morning trading.

Explore further

Large Candida auris outbreak linked to multi-use thermometers in UK ICU

© 2019 AFP

Citation: J&J buys medical robotics company for $3.4 bn (2019, February 13) retrieved 22 July 2019 from https://medicalxpress.com/news/2019-02-jj-medical-robotics-company-bn.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more